Home

Neil Herskowitz

CIK 1298246 · last filed 2026-07-02

Neil Herskowitz is a corporate insider who has filed 62 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for DERM, was dated Jul 2, 2026. Across all open-market trades the lifetime net is +$375.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.91M

Companies

9

Total Filings

62

Lifetime Open-Market Net

$375.5K

Filer Profile

Reported Address
2109 BROADWAY, SUITE 206
NEW YORK, NY 10023
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DERM Director 168,618 $7.23 $1.22M $0 8 2026-07-02
MBIO Director 145 $0.51 $74 $3.7K 7 2025-12-30
Checkpoint Therapeutics, Inc. (CKPT) Delisted Director 0 $4.26 $0 $0 9 2025-05-30
AVENUE THERAPEUTICS, INC. (ATXI) Delisted Director 97 $0.35 $34 $321.8K 20 2024-12-03
NATIONAL HOLDINGS CORP (NHLDW) Delisted Director 60,593 — — $0 1 2019-03-06
Origo Acquisition Corp (CNLM.W) Delisted Director 0 — — $0 1 2016-05-23
TGTX Director 68,550 $53.89 $3.69M $0 1 2013-06-07
Chelsea Therapeutics International, Ltd. (CHTP) Delisted Director 59,522 — — $0 2 2008-01-28
TG THERAPEUTICS, INC. (MHA) Delisted Director 93,626 — — $50.0K 2 2007-04-09

Recent Filings

62 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-02 DERM Grant (A) +50,000 $0 EDGAR
2026-06-26 DERM Grant (A) +10,000 $0 EDGAR
2025-12-30 MBIO Sell (S) −247 -$238 EDGAR
2025-08-07 DERM Grant (A) +20,000 $0 EDGAR
2025-07-07 DERM Grant (A) +7,173 $0 EDGAR
2025-05-30 Checkpoint Therapeutics, Inc. (CKPT) Delisted Mixed −134,812 $0 EDGAR
2024-12-17 Checkpoint Therapeutics, Inc. (CKPT) Delisted Grant (A) +17,638 $0 EDGAR
2024-12-03 AVENUE THERAPEUTICS, INC. (ATXI) Delisted Sell (S) −23 -$46 EDGAR
2024-09-25 AVENUE THERAPEUTICS, INC. (ATXI) Delisted Grant (A) — $0 EDGAR
2024-07-10 DERM Grant (A) +9,728 $0 EDGAR
Showing 1–10 of 62
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.